SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013149
Filing Date
2022-05-13
Accepted
2022-05-13 06:10:50
Documents
77
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm   iXBRL 10-Q 1140248
2 ex4-15.htm EX-4.15 107430
3 ex4-16.htm EX-4.16 105724
4 ex10-1.htm EX-10.1 249843
5 ex10-2.htm EX-10.2 204261
6 ex31-1.htm EX-31.1 16734
7 ex31-2.htm EX-31.2 16858
8 ex32-1.htm EX-32.1 9198
  Complete submission text file 0001493152-22-013149.txt   7308027

Data Files

Seq Description Document Type Size
9 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qlgn-20220331.xsd EX-101.SCH 58347
10 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qlgn-20220331_cal.xml EX-101.CAL 61985
11 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qlgn-20220331_def.xml EX-101.DEF 238974
12 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qlgn-20220331_lab.xml EX-101.LAB 432610
13 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qlgn-20220331_pre.xml EX-101.PRE 349534
71 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 1149222
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 22920115
SIC: 2834 Pharmaceutical Preparations